SCHEMBL14101585

SCHEMBL14101585

c1ccc(-c2ccc3ccc4c(-c5ccc(-c6ccc7c(c6)sc6cc(-c8ccc(-c9ccc%10ccc%11c(-c%12ccccc%12)ccc%12ccc9c%10c%12%11)cc8)ccc67)cc5)ccc5ccc2c3c54)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.41
PI4KA P42356 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
LIMK1 P53667 1/20 0.40
F9 P00740 3/20 0.38
PIM3 Q86V86 1/20 0.37
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
MAPT P10636 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.35
APAF1 O14727 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101638 1.00 PIK3CA (0.41) PIK3CAPI4KAPI4KBLIMK1F9
SCHEMBL14101628 0.98 LIMK1 (0.40) PIK3CAPI4KAPI4KBLIMK1F9
SCHEMBL14101627 0.98 LIMK1 (0.40) PIK3CAPI4KAPI4KBLIMK1F9
SCHEMBL14101571 0.97 LIMK1 (0.38) PIK3CAPI4KAPI4KBLIMK1F9
SCHEMBL14101639 0.95 CYP1A2 (0.40) PIK3CAPI4KAPI4KBLIMK1F9
SCHEMBL14101590 0.95 CYP1A2 (0.40) PIK3CAPI4KAPI4KBLIMK1F9
SCHEMBL14101645 0.95 LIMK1 (0.38) PIK3CAPI4KAPI4KBLIMK1F9
SCHEMBL14101574 0.95 LIMK1 (0.38) PIK3CAPI4KAPI4KBLIMK1F9
SCHEMBL14101572 0.95 F9 (0.38) PIK3CAPI4KAPI4KBLIMK1F9
SCHEMBL14101607 0.94 CYP1A2 (0.39) PIK3CAPI4KAPI4KBLIMK1F9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR PIK3CA 4815/4885PI4KA 4381/4885PI4KB 4379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.